#### Faculty of Health and Medical Sciences, University of Copenhagen

 
**We are looking for a highly motivated and dynamic postdoc for a 3-year position to join the Lund Group.**

Our research 
Our team aims to understand how ribosome specialization leads to the instalment of translational programs and how these processes are hijacked in human disease. Due to the central role of the ribosome in many biological processes, we use a broad panel of model systems, including human stem cells, neuronal cultures, and 2D and 3D cultures of human cells and patient samples.

The team is highly international, and we have a broad range of local and international collaborators. We believe that cooperation and collegiality are essential elements for research successes. You can find more information about the team and our work here: https://www.bric.ku.dk/research-groups/Research/lund_group/

The project
You will join the Lund Group focusing on ribosome heterogeneity and specialized translation. We use a broad array of wet lab and computational techniques and develop new techniques to push our research forward. We highly value collaboration and cocreation and you will have freedom to codevelop the project.  Your project will be to explore how pathological translation programs contribute to the development of colorectal cancer. You will use both mouse and human organoid cultures, and key techniques will likely involve ribosome profiling, RiboMeth-seq and mass spectrometry. The methods are established in the laboratory or available through core facilities.

Profile

We are looking for a highly motivated and enthusiastic scientist with the following competencies and experience:

Essential experience and skills:

You have a PhD in biomedical or natural sciences
You are highly experienced in molecular and cellular biology
Proficient communication skills and ability to work in teams
Excellent English skills written and spoken

Desirable experience and skills:

Prior experience in cancer research is an advantage
Prior experience in working with protein synthesis/translation is an advantage
Computational skills would be an advantage

Place of employment

The place of employment is at the Biotech Research and Innovation Centre, University of Copenhagen (www.bric.ku.dk). We offer creative and stimulating working conditions in dynamic and international research environment. Our research facilities include modern laboratories and opportunities for networking and training through our Postdoc Career Program (https://www.bric.ku.dk/phd-and-postdoc-programme/postdoc-career-programme).

Terms of employment

The average weekly working hours are 37 hours per week.

The position is a fixed-term position limited to a period of 3 years. The position is available now and the start date is after agreement.

Salary, pension and other conditions of employment are set in accordance with the Agreement between the Ministry of Taxation and AC (Danish Confederation of Professional Associations) or other relevant organisation. Currently, the monthly salary starts at 38,575 DKK/approx. 5,171 EUR (April 2024 level). Depending on qualifications, a supplement may be negotiated. The employer will pay an additional 17.1 % to your pension fund.

Foreign and Danish applicants may be eligible for tax reductions, if they hold a PhD degree and have not lived in Denmark the last 10 years.

The position is covered by the Job Structure for Academic Staff at Universities 2020.

Questions

For further information please contact Anders H. Lund (anders.lund@bric.ku.dk).

Foreign applicants may find this link useful: www.ism.ku.dk (International Staff Mobility).

Application procedure

Your online application must be submitted in English by clicking ‘Apply now’ below. Furthermore, your application must include the following documents/attachments – all in PDF format:

Motivated letter of application (max. one page).
CV incl. education, work/research experience, language skills and other skills relevant for the position.
A certified/signed copy of a) PhD certificate and b) Master of Science certificate. If the PhD is not completed, a written statement from the supervisor will do.
List of publications.

**Deadline for applications: 29 September 2024, 23.59pm CET**

We reserve the right not to consider material received after the deadline, and not to consider applications that do not live up to the abovementioned requirements. 

The further process

After the expiry of the deadline for applications, the authorized recruitment manager selects applicants for assessment on the advice of the hiring committee. All applicants are then immediately notified whether their application has been passed for assessment by an unbiased assessor. Once the assessment work has been completed each applicant has the opportunity to comment on the part of the assessment that relates to the applicant him/herself.

You can read about the recruitment process at http://employment.ku.dk/faculty/recruitment-process/

The applicant will be assessed according to the Ministerial Order no. 242 of 13 March 2012 on the Appointment of Academic Staff at Universities.

Interviews are expected to be held in week 44-45

The University of Copenhagen wish to reflect the diversity of society and encourage all qualified candidates to apply regardless of personal background.


Postdoc in Ribosome Specialization in Colorectal Cancer at the Biotech Research and Innovation Centre; We are looking for a highly motivated and dynamic postdoc for a 3-year position to join the Lund Group. Application due 9/29/2024. Start date 1/1/2025. 

Postdoc in Ribosome Specialization in Colorectal Cancer

 COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu) | The TRANSLACORE Cost Action is bridging disciplines and expertise across Europe in order to advance an emerging field in cancer biology: translational control in cancer. It is providing a unique opportunity to understand this biological process leading to reconsider our view of gene expression control in this disease and deliver novel therapeutic opportunities.

Search in the Translacore

Postdoc in Ribosome Specialization in Colorectal Cancer